The short version of actin binding fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-06-17 and is reviewed periodically as new material appears.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
The four substrates of this enzyme are 4-hydroxyphenylacetic acid, reduced nicotinamide adenine dinucleotide (NADH), oxygen and a proton. Its products are homogentisic acid, oxidised NAD+, and water. The enzyme can use nicotinamide adenine dinucleotide phosphate as an alternative cofactor. The enzyme is a flavin-containing monooxygenase that uses molecular oxygen as oxidant and incorporates one of its atoms into the starting material. The systematic name of this enzyme class is 4-hydroxyphenylacetate,NAD(P)H:oxygen oxidoreductase (1-hydroxylating). Other names in common use include 4-hydroxyphenylacetate 1-hydroxylase, 4-hydroxyphenylacetic 1-hydroxylase, and 4-HPA 1-hydroxylase. This enzyme participates in tyrosine metabolism.
Ruth Levitas (born 15 May 1949 in London) is emeritus Professor in the Department of Sociology at the University of Bristol. She is well known internationally for her research on utopia and utopian studies. Her book, The Concept of Utopia (1990), addresses the notion of the ideal society throughout European history. Her follow-on book, Utopia as Method: The Imaginary Reconstitution of Society (2013), makes the case that 'utopia should be understood as a method rather than a goal.' She has formulated a program of sociology which is fundamentally utopian-focused in conventional sociological discourse. In The Inclusive Society?: Social Exclusion and New Labour (2005), Levitas introduced the idea of social exclusion as part of the new political language. She also introduced the concepts of MUD (the moral underclass discourse), SID (the social integration discourse), and RED (the redistribution discourse), as tools for analysing social exclusion.
The predominance of the balance of power in the practice of statesmen for three centuries … should not obscure the fact that throughout world history periods dominated by the balance-of-power policies have not been the rule. The balance of power scarcely existed anywhere as a conscious principle of international politics before 1500… Evoking examples of the ancient Chinese and Roman civilizations, Quincy Wright added:
=== Climate === Lower Saxony falls climatically into the north temperate zone of central Europe that is affected by prevailing Westerlies and is located in a transition zone between the maritime climate of Western Europe and the continental climate of Eastern Europe. This transition is clearly noticeable within the state: while the northwest experiences an Atlantic (North Sea coastal) to Sub-Atlantic climate, with comparatively low variations in temperature during the course of the year and a surplus water budget, the climate towards the southeast is increasingly affected by the Continent. This is clearly shown by greater temperature variations between the summer and winter halves of the year and in lower and more variable amounts of precipitation across the year. This sub-continental effect is most sharply seen in the Wendland, in the Weser Uplands (Hamelin to Göttingen) and in the area of Helmstedt. The highest levels of precipitation are experienced in the Harz because the Lower Saxon part forms the windward side of this mountain range against which orographic rain falls. The average annual temperature is 8 °C (46 °F); 7.5 °C (45.5 °F) in the Altes Land and 8.5 °C (47.3 °F) in the district of Cloppenburg.
Sources: en.wikipedia.org
Nickel-78 is one of the element's heaviest known isotopes. With 28 protons and 50 neutrons, nickel-78 is doubly magic, resulting in much greater nuclear binding energy and stability despite a lopsided neutron-proton ratio. Its half-life is 122 ± 5.1 milliseconds. Due to its magic neutron number, 78Ni is believed to have an important role in supernova nucleosynthesis of elements heavier than iron. 78Ni, along with N = 50 isotones 79Cu and 80Zn, are thought to constitute a waiting point in the r-process, where further neutron capture is delayed by the shell gap and a buildup of isotopes around A = 80 results.
Like other cluster decays, alpha decay is fundamentally a quantum tunneling process. Unlike beta decay, it is governed by the interplay between both the strong nuclear force and the electromagnetic force. Alpha particles have a typical kinetic energy of 5 MeV (or ≈ 0.13% of their total energy, 110 TJ/kg) and have a speed of about 15,000,000 m/s, or 5% of the speed of light. There is surprisingly small variation around this energy, due to the strong dependence of the half-life of this process on the energy produced. Because of their relatively large mass, the electric charge of +2 e and relatively low velocity, alpha particles are very likely to interact with other atoms and lose their energy, and their forward motion can be stopped by a few centimeters of air. Approximately 99% of the helium produced on Earth is the result of the alpha decay of underground deposits of minerals containing uranium or thorium. The helium is brought to the surface as a by-product of natural gas production.
== Second round proper == The draw for the second round was made on BBC Two on 7 November 2022 by Jermaine Beckford and Mickey Thomas at the Racecourse Ground in Wrexham, and consisted of the 40 winners from the previous round. The round contained one team from the seventh tier, Alvechurch, who defeated EFL League One club Cheltenham Town in the first round.
==== Conducting Wire ==== Due to Graphene's high electrical and thermal conductivity, mechanical strength, and corrosion resistance, one potential application is in high-power energy transmission. Copper wire has long been used for power transmission for its high conductivity, ductility, and low costs. However, traditional wire fails to meet the transmission requirements of many new technologies. Thermally dependent resistivity in mesoscopic copper wire limits efficiency and current carrying capacity in small-scale electronics. Additionally, copper wire exhibits internal failure by electromigration at high current density, limiting miniaturization of wire. Copper's high weight and low temperature oxidation also limit its applications in high-power transmission. Increasing demand for high ampacity transmission in electronics and electric vehicle applications necessitate improvements in conductor technology. Graphene-copper composite conductors are a promising alternative to standard conductors in high-power applications. In 2013, researchers demonstrated a one-hundred-fold increase in current carrying capacity with carbon nanotube-copper composite wires when compared to traditional copper wire. These composite wires exhibited a temperature coefficient of resistivity an order of magnitude smaller than copper wires, an important feature for high load applications.
Combinatorial biology is the generation of large numbers of molecules (usually peptides, enzymes or other polypeptides in biology) with non-natural metabolic pathways. The resulting set of molecules is referred to as a library. Because traditional methods of chemical discovery and selection relied on "natural" pathways (those formed by sources found in the wild and brought into the library), creation of the requisite number of peptides for new drug discovery was impractical. New drugs needed to be built from specific combinations of proteins among the trillions of possible combinations. Synthetic avenues for peptide generation became an important venue for drug creation in the 1980s. In 1985, Houghten's most cited paper (cited 650 times, according to Scopus) published his method for the synthesis of massive numbers of peptides—enough for practical use in pharmacological work—in the Proceedings of the National Academy of Sciences. This method was referred to as the "tea-bag" method because deprotected peptides are enclosed in mesh bags and dipped quickly into liquid solutions containing activated amino acids (or other organic compounds). The peptide is thus elongated one amino acid at each step, and by careful movement of each teabag, a series of related peptides can be made. By another variation, "split and mix", tens of millions of very diverse peptides can be made, and then assayed by some technique. Very precise deconvolution of the results, or alternatively, marking the peptide beads, can correlate sequence and activity.
Sources: en.wikipedia.org
=== Immunology === Immunology is the branch of medicine that deals with the immune system, a network of biological systems that protects humans from diseases. The immune system detects and responds to pathogens, such as viruses, bacteria, and parasites, as well as cancer cells and foreign bodies. Humans have two major immune subsystems: The innate immune system, which provides a preconfigured response (e.g. defensins, complement system) to broad groups of situations and stimuli; and the adaptive immune system, which provides a tailored response to each stimulus by developing an immunological memory of molecules previously encountered. Mechanisms common to both subsystems, include phagocytosis, humoural immunity, cell-mediated immunity.
Evocative/suppression testing refers to a class of tests performed where one substance is measured both before and after the administration of another substance to determine if the levels are stimulated ("evocative") or suppressed. They are most commonly performed in the evaluation of possible endocrine disorders. Certain tests are performed in the evaluation of multiple conditions, and not all listed substances may be measured in each test. Examples include:
Crotonyl-coenzyme A (crotonyl-CoA) is an intermediate in the fermentation of butyric acid, and in the metabolism of lysine and tryptophan. It is important in the metabolism of fatty acids and amino acids. Crotonyl-CoA is also involved in β-oxidation, where it is formed from butyryl-CoA through the action of acyl-CoA dehydrogenases, linking fatty acid breakdown to cellular energy production.
== Malignant neoplasm of lip, oral cavity, and pharynx (140–149) == 140 Malignant neoplasm of lip 141 Malignant neoplasm of tongue 142 Malignant neoplasm of major salivary glands 143 Malignant neoplasm of gum 144 Malignant neoplasm of floor of mouth 145 Malignant neoplasm of other and unspecified parts of mouth 146 Malignant neoplasm of oropharynx 147 Malignant neoplasm of nasopharynx 148 Malignant neoplasm of hypopharynx 149 Malignant neoplasm of other and ill-defined sites within the lip
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.